{"transactions":[{"id":747791,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:39:36.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001867096-26-000041","document":"wk-form4_1780699173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709626000041/wk-form4_1780699173.xml","form_type":"4"}},{"id":747790,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:39:36.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":238337,"source":{"system":"sec-edgar","filing":"0001867096-26-000041","document":"wk-form4_1780699173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709626000041/wk-form4_1780699173.xml","form_type":"4"}},{"id":905990,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-02-13T17:53:41.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":773,"derivative":{"underlying":"Common Stock","underlying_shares":897},"source":{"system":"sec-edgar","filing":"0000920148-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000074/form4.xml","form_type":"4"}},{"id":905989,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-13T17:53:41.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":897,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."}],"balance_after":13739,"source":{"system":"sec-edgar","filing":"0000920148-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000074/form4.xml","form_type":"4"}},{"id":908471,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-02-12T16:28:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 10, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1670,"derivative":{"underlying":"Common Stock","underlying_shares":773},"source":{"system":"sec-edgar","filing":"0000920148-26-000059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000059/form4.xml","form_type":"4"}},{"id":1122774,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T22:59:28.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders."}],"balance_after":214144,"source":{"system":"sec-edgar","filing":"0001867096-25-000106","document":"wk-form4_1749077962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709625000106/wk-form4_1749077962.xml","form_type":"4"}},{"id":1270203,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-02-13T13:23:31.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 11, 2026."}],"balance_after":897,"derivative":{"underlying":"Common Stock","underlying_shares":897},"source":{"system":"sec-edgar","filing":"0001127602-25-004517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004517/form4.xml","form_type":"4"}},{"id":1277246,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T13:52:56.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":false,"shares":944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 6, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":944},"source":{"system":"sec-edgar","filing":"0001127602-25-003707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003707/form4.xml","form_type":"4"}},{"id":1277245,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-10T13:52:56.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":true,"shares":944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."}],"balance_after":12842,"source":{"system":"sec-edgar","filing":"0001127602-25-003707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003707/form4.xml","form_type":"4"}},{"id":1489895,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T20:18:26.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 5, 2025 or the date of the Company's next annual meeting of stockholders."}],"balance_after":164144,"source":{"system":"sec-edgar","filing":"0001867096-24-000104","document":"wk-form4_1717618697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709624000104/wk-form4_1717618697.xml","form_type":"4"}},{"id":1556177,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T21:45:09.000Z","date":"2024-03-15","kind":"other","planned":false,"acquired":true,"shares":6474,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Keveyis Sales 2023 Milestone achieved resulting in the settlement of the related Contingent Value Right (\"CVR\") in shares of Xeris Biopharma Holdings, Inc. (the \"Company\")'s Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on October 5, 2021, the effective time of the Merger (as defined below), pursuant to the transaction agreement dated as of May 24, 2021 by and among Xeris Pharmaceuticals, Inc. (\"Xeris\"), Strongbridge Biopharma plc (\"Strongbridge\"), the Issuer (\"HoldCo\") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo (\"MergerSub\"), where HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge, and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of shares of Common Stock for the CVR is equal to the product (A) $0.25 divided by the volume weighted average price for the Company's Common Stock as reported by\nNasdaq for the ten (10) Trading Days immediately prior to October 5, 2021 and (B) the number of CVRs held by the holder as reflected on the CVR Register."}],"balance_after":114144,"source":{"system":"sec-edgar","filing":"0001867096-24-000041","document":"wk-form4_1712007900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709624000041/wk-form4_1712007900.xml","form_type":"4"}},{"id":1654062,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T17:47:57.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vested fully on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vested fully on February 7, 2024."}],"balance_after":944,"derivative":{"underlying":"Common Stock","underlying_shares":947},"source":{"system":"sec-edgar","filing":"0001127602-24-003889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003889/form4.xml","form_type":"4"}},{"id":1654061,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T17:47:57.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc."}],"balance_after":1891,"derivative":{"underlying":"Common Stock","underlying_shares":944},"source":{"system":"sec-edgar","filing":"0001127602-24-003889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003889/form4.xml","form_type":"4"}},{"id":1654060,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-08T17:47:57.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":947,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":11898,"source":{"system":"sec-edgar","filing":"0001127602-24-003889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003889/form4.xml","form_type":"4"}},{"id":1863778,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-07T21:00:54.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders."}],"balance_after":107670,"source":{"system":"sec-edgar","filing":"0001867096-23-000101","document":"wk-form4_1686171645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709623000101/wk-form4_1686171645.xml","form_type":"4"}},{"id":1936795,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-28T21:59:10.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.188,"expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001362118-23-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000136211823000021/primary_doc.xml","form_type":"4"}},{"id":2017688,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T20:15:24.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":849,"derivative":{"underlying":"Common Stock","underlying_shares":742},"source":{"system":"sec-edgar","filing":"0001127602-23-005110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005110/form4.xml","form_type":"4"}},{"id":2017687,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-14T20:15:24.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":742,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":10951,"source":{"system":"sec-edgar","filing":"0001127602-23-005110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005110/form4.xml","form_type":"4"}},{"id":2025281,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-02-09T17:34:02.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1591,"derivative":{"underlying":"Common Stock","underlying_shares":849},"source":{"system":"sec-edgar","filing":"0001127602-23-004134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223004134/form4.xml","form_type":"4"}},{"id":2060260,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T21:55:40.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":2.7183,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000147450623000008/primary_doc.xml","form_type":"4"}},{"id":2106801,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Voting Convertible Preferred Stock","published_at":"2022-11-22T22:14:53.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":335000,"price":2,"value":670000.0,"ownership":{"direct":false,"nature":"HealthQuest Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Voting Preferred Stock will convert into shares of Common Stock on a one for ten basis (i) at the option the holder or (ii) at the option of the Company within 30 days following the occurrence of certain events. The Voting Preferred Stock votes with the Common Stock on an as-converted basis.  The Voting Preferred Stock does not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Voting Preferred Stock will convert into shares of Common Stock on a one for ten basis (i) at the option the holder or (ii) at the option of the Company within 30 days following the occurrence of certain events. The Voting Preferred Stock votes with the Common Stock on an as-converted basis.  The Voting Preferred Stock does not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were purchased by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest.  The Reporting Person and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":335000,"derivative":{"exercise_price":0,"exercise_date":"2022-11-18","underlying":"Common Stock","underlying_shares":3350000},"source":{"system":"sec-edgar","filing":"0001567619-22-020788","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000156761922020788/doc1.xml","form_type":"4"}},{"id":2237653,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T23:05:38.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such options will vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders."}],"balance_after":25000,"derivative":{"exercise_price":2.1,"exercise_date":"2022-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001867096-22-000097","document":"wf-form4_165481592522339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709622000097/wf-form4_165481592522339.xml","form_type":"4"}},{"id":2237652,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T23:05:38.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders."}],"balance_after":65170,"source":{"system":"sec-edgar","filing":"0001867096-22-000097","document":"wf-form4_165481592522339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709622000097/wf-form4_165481592522339.xml","form_type":"4"}},{"id":2316541,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-28T17:25:19.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.38,"expiration_date":"2032-03-25","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001362118-22-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000136211822000029/primary_doc.xml","form_type":"4"}},{"id":2395345,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T17:32:16.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 11, 2023."}],"balance_after":742,"derivative":{"underlying":"Common Stock","underlying_shares":742},"source":{"system":"sec-edgar","filing":"0001127602-22-004955","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222004955/form4.xml","form_type":"4"}},{"id":2412117,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-02-04T14:05:06.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 2, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001127602-22-003269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003269/form4.xml","form_type":"4"}},{"id":2412116,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-04T14:05:06.000Z","date":"2022-02-02","kind":"exercise","acquired":true,"shares":771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":10209,"source":{"system":"sec-edgar","filing":"0001127602-22-003269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003269/form4.xml","form_type":"4"}},{"id":2465810,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-12-17T21:15:32.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":1600000,"price":1.25,"value":2000000.0,"ownership":{"direct":false,"nature":"Held by HealthQuest Partners II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were purchased by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest.  The Reporting Person and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":6795621,"source":{"system":"sec-edgar","filing":"0001567619-21-022249","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000156761921022249/doc1.xml","form_type":"4"}},{"id":2524468,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T01:09:05.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on June 15, 2022, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":4.05,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-21-000164","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000147450621000164/primary_doc.xml","form_type":"4"}},{"id":2545422,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":19650,"price":2.37,"value":46570.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of these options shall vest in equal annual installments until the third anniversary of the date of grant."}],"balance_after":19650,"derivative":{"exercise_price":2.37,"expiration_date":"2031-10-05","underlying":"Common Stock","underlying_shares":19650},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545421,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":9.89,"expiration_date":"2028-05-15","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545420,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":5.62,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545419,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":7.02,"expiration_date":"2026-05-12","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545418,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":7357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":7357,"derivative":{"exercise_price":22.39,"expiration_date":"2025-10-16","underlying":"Common Stock","underlying_shares":7357},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545417,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":19600,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":19600,"derivative":{"exercise_price":22.39,"expiration_date":"2025-10-16","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2545416,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T22:30:49.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":50170,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 5, 2021, pursuant to the transaction agreement dated as of May 24, 2021 (\"Transaction Agreement\") by and among Xeris Pharmaceuticals, Inc. (\"Xeris\"), Strongbridge Biopharma plc (\"Strongbridge\"), the Issuer (\"HoldCo\") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo (\"MergerSub\"), HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge (the \"Acquisition\"), and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the \"Merger\", and together with the Acquisition, the \"Transaction\"). At the effective time of the Merger (the \"Merger Effective Time\"), all existing ordinary shares of Strongbridge were cancelled and automatically converted into the right to receive HoldCo common stock on a 0.7840-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 5, 2021, pursuant to the transaction agreement dated as of May 24, 2021 (\"Transaction Agreement\") by and among Xeris Pharmaceuticals, Inc. (\"Xeris\"), Strongbridge Biopharma plc (\"Strongbridge\"), the Issuer (\"HoldCo\") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo (\"MergerSub\"), HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge (the \"Acquisition\"), and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the \"Merger\", and together with the Acquisition, the \"Transaction\"). At the effective time of the Merger (the \"Merger Effective Time\"), all existing ordinary shares of Strongbridge were cancelled and automatically converted into the right to receive HoldCo common stock on a 0.7840-for-one basis."}],"balance_after":50170,"source":{"system":"sec-edgar","filing":"0000899243-21-039750","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039750/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547094,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T23:41:14.000Z","date":"2021-10-05","kind":"disposition_to_issuer","acquired":false,"shares":154385,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Under the Agreement, each option to purchase ordinary shares of Issuer was automatically converted into an option to acquire a number of shares of HoldCo common stock determined by multiplying the number of ordinary shares of Issuer subject to such option by 0.784 (rounded down to the nearest whole share), at an exercise price per share (rounded up to the nearest whole cent) determined by dividing the per-share exercise price of Issuer option by 0.784, with the same terms and conditions as applied to the applicable option prior to closing of the transaction. HoldCo issued one CVR with respect to each ordinary share of Issuer subject to each option prior to the adjustment described herein, subject to the same vesting and forfeiture conditions applicable to the corresponding option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Under the Agreement, each option to purchase ordinary shares of Issuer was automatically converted into an option to acquire a number of shares of HoldCo common stock determined by multiplying the number of ordinary shares of Issuer subject to such option by 0.784 (rounded down to the nearest whole share), at an exercise price per share (rounded up to the nearest whole cent) determined by dividing the per-share exercise price of Issuer option by 0.784, with the same terms and conditions as applied to the applicable option prior to closing of the transaction. HoldCo issued one CVR with respect to each ordinary share of Issuer subject to each option prior to the adjustment described herein, subject to the same vesting and forfeiture conditions applicable to the corresponding option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Under the Agreement, each option to purchase ordinary shares of Issuer was automatically converted into an option to acquire a number of shares of HoldCo common stock determined by multiplying the number of ordinary shares of Issuer subject to such option by 0.784 (rounded down to the nearest whole share), at an exercise price per share (rounded up to the nearest whole cent) determined by dividing the per-share exercise price of Issuer option by 0.784, with the same terms and conditions as applied to the applicable option prior to closing of the transaction. HoldCo issued one CVR with respect to each ordinary share of Issuer subject to each option prior to the adjustment described herein, subject to the same vesting and forfeiture conditions applicable to the corresponding option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Under the Agreement, each option to purchase ordinary shares of Issuer was automatically converted into an option to acquire a number of shares of HoldCo common stock determined by multiplying the number of ordinary shares of Issuer subject to such option by 0.784 (rounded down to the nearest whole share), at an exercise price per share (rounded up to the nearest whole cent) determined by dividing the per-share exercise price of Issuer option by 0.784, with the same terms and conditions as applied to the applicable option prior to closing of the transaction. HoldCo issued one CVR with respect to each ordinary share of Issuer subject to each option prior to the adjustment described herein, subject to the same vesting and forfeiture conditions applicable to the corresponding option."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":154385},"source":{"system":"sec-edgar","filing":"0001179110-21-009278","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911021009278/edgar.xml","form_type":"4"}},{"id":2547093,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-10-06T23:41:14.000Z","date":"2021-10-05","kind":"disposition_to_issuer","acquired":false,"shares":63993,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ordinary shares of Issuer were converted into shares of common stock of Xeris Biopharma Holdings, Inc. (\"HoldCo\") pursuant to the Transaction Agreement (the \"Agreement\"), dated May 24, 2021, among the Issuer, Xeris Pharmaceuticals, Inc., HoldCo and Wells MergerSub, Inc. Under the Agreement, each ordinary share of Issuer was exchanged for 0.784 of a share of HoldCo common stock, and cash in lieu of fractional shares, plus one contingent value right (a \"CVR\") worth up to an additional $1.00, payable in cash, HoldCo common stock or a combination thereof at HoldCo's sole election."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Ordinary shares of Issuer were converted into shares of common stock of Xeris Biopharma Holdings, Inc. (\"HoldCo\") pursuant to the Transaction Agreement (the \"Agreement\"), dated May 24, 2021, among the Issuer, Xeris Pharmaceuticals, Inc., HoldCo and Wells MergerSub, Inc. Under the Agreement, each ordinary share of Issuer was exchanged for 0.784 of a share of HoldCo common stock, and cash in lieu of fractional shares, plus one contingent value right (a \"CVR\") worth up to an additional $1.00, payable in cash, HoldCo common stock or a combination thereof at HoldCo's sole election."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-21-009278","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911021009278/edgar.xml","form_type":"4"}},{"id":2548658,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":9.89,"expiration_date":"2028-05-15","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548657,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":5.62,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548656,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":31360,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":31360,"derivative":{"exercise_price":7.02,"expiration_date":"2026-05-12","underlying":"Common Stock","underlying_shares":31360},"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548655,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":7357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":7357,"derivative":{"exercise_price":22.39,"expiration_date":"2025-10-16","underlying":"Common Stock","underlying_shares":7357},"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548654,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":19600,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Merger Effective Time, each option to purchase ordinary shares of Strongbridge (the \"Strongbridge Option\") that was outstanding immediately prior to the Merger Effective Time, whether vested or unvested, was automatically converted into an option to purchase shares of HoldCo common stock (the \"HoldCo Option\") on a 0.7840-for-one basis, on the same terms and conditions (including any applicable vesting and exercisability requirements) as were applicable to such Strongbridge Option immediately prior to the Merger Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested as of the date hereof."}],"balance_after":19600,"derivative":{"exercise_price":22.39,"expiration_date":"2025-10-16","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548653,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T23:53:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":50170,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 5, 2021, pursuant to the transaction agreement dated as of May 24, 2021 (\"Transaction Agreement\") by and among Xeris Pharmaceuticals, Inc. (\"Xeris\"), Strongbridge Biopharma plc (\"Strongbridge\"), the Issuer (\"HoldCo\") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo (\"MergerSub\"), HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge (the \"Acquisition\"), and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the \"Merger\", and together with the Acquisition, the \"Transaction\"). At the effective time of the Merger (the \"Merger Effective Time\"), all existing ordinary shares of Strongbridge were cancelled and automatically converted into the right to receive HoldCo common stock on a 0.7840-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 5, 2021, pursuant to the transaction agreement dated as of May 24, 2021 (\"Transaction Agreement\") by and among Xeris Pharmaceuticals, Inc. (\"Xeris\"), Strongbridge Biopharma plc (\"Strongbridge\"), the Issuer (\"HoldCo\") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo (\"MergerSub\"), HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge (the \"Acquisition\"), and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the \"Merger\", and together with the Acquisition, the \"Transaction\"). At the effective time of the Merger (the \"Merger Effective Time\"), all existing ordinary shares of Strongbridge were cancelled and automatically converted into the right to receive HoldCo common stock on a 0.7840-for-one basis."}],"balance_after":50170,"source":{"system":"sec-edgar","filing":"0000899243-21-039342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000089924321039342/doc4.xml","form_type":"4"}},{"id":2548652,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-10-05T23:22:19.000Z","date":"2021-10-01","kind":"tax_withholding","acquired":false,"shares":17763,"price":2.06,"value":36591.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units."}],"balance_after":63993,"source":{"system":"sec-edgar","filing":"0001179110-21-009219","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911021009219/edgar.xml","form_type":"4"}},{"id":2707771,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-18T23:11:42.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest in full on May 18, 2022, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":81756,"source":{"system":"sec-edgar","filing":"0001179110-21-005556","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911021005556/edgar.xml","form_type":"4"}},{"id":2710219,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-17T23:27:16.000Z","date":"2021-05-14","kind":"tax_withholding","acquired":false,"shares":19200,"price":2.35,"value":45120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units."}],"balance_after":41756,"source":{"system":"sec-edgar","filing":"0001179110-21-005450","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911021005450/edgar.xml","form_type":"4"}},{"id":2767916,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-03-31T01:47:37.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-21-007259","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000156761921007259/doc1.xml","form_type":"4"}},{"id":2875227,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-02-08T19:57:24.000Z","date":"2021-02-04","kind":"exercise","acquired":false,"shares":986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":771,"derivative":{"underlying":"Common Stock","underlying_shares":986},"source":{"system":"sec-edgar","filing":"0001127602-21-004331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760221004331/form4.xml","form_type":"4"}},{"id":2875226,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-08T19:57:24.000Z","date":"2021-02-04","kind":"exercise","acquired":true,"shares":986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":9438,"source":{"system":"sec-edgar","filing":"0001127602-21-004331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760221004331/form4.xml","form_type":"4"}},{"id":2879709,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-02-05T01:40:26.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 2, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1757,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001127602-21-004075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760221004075/form4.xml","form_type":"4"}},{"id":3103031,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T20:51:31.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal monthly installments over 12 months starting one month after the grant date (June 18, 2020), provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":3333,"derivative":{"exercise_price":6.7,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001267602-20-000100","document":"wf-form4_159285907021394.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000126760220000100/wf-form4_159285907021394.xml","form_type":"4"}},{"id":3105380,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-18T20:44:51.000Z","date":"2020-06-16","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A Preferred Stock were originally purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant exercisable for one share of Common Stock, at an exercise price of $3.50 per share). Each share of Series A Preferred Stock converted into ten shares of Common Stock for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_date":"2020-06-16","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001435183-20-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000143518320000003/edgar.xml","form_type":"4"}},{"id":3105379,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:44:51.000Z","date":"2020-06-16","kind":"exercise","acquired":true,"shares":1200000,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A Preferred Stock were originally purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant exercisable for one share of Common Stock, at an exercise price of $3.50 per share). Each share of Series A Preferred Stock converted into ten shares of Common Stock for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":5195621,"source":{"system":"sec-edgar","filing":"0001435183-20-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000143518320000003/edgar.xml","form_type":"4"}},{"id":3142559,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-19T23:29:43.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":100000,"price":35.4737,"value":3547370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 12, 2020. The actual sale prices ranged from a low of $35.175 to a high of $35.665, inclusive. Each Reporting Person undertakes to provide upon request of the SEC Staff, Castle Biosciences, Inc. or a Castle Biosciences, Inc. security holder full information regarding the number of shares sold at each price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1433577,"source":{"system":"sec-edgar","filing":"0001104659-20-063888","document":"tm2019858-1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920063888/tm2019858-1_4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":3142558,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-19T23:29:43.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":100000,"price":34.2537,"value":3425370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 12, 2020. The actual sale prices ranged from a low of $34.0861 to a high of $34.6399, inclusive. Each Reporting Person undertakes to provide upon request of the SEC Staff, Castle Biosciences, Inc. or a Castle Biosciences, Inc. security holder full information regarding the number of shares sold at each price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1533577,"source":{"system":"sec-edgar","filing":"0001104659-20-063888","document":"tm2019858-1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920063888/tm2019858-1_4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":3142557,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-19T23:29:43.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":50000,"price":33.037,"value":1651850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 12, 2020. The actual sale prices ranged from a low of $33.034 to a high of $33.04, inclusive. Each Reporting Person undertakes to provide upon request of the SEC Staff, Castle Biosciences, Inc. or a Castle Biosciences, Inc. security holder full information regarding the number of shares sold at each price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1633577,"source":{"system":"sec-edgar","filing":"0001104659-20-063888","document":"tm2019858-1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920063888/tm2019858-1_4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":3145320,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-18T20:51:36.000Z","date":"2020-05-15","kind":"tax_withholding","acquired":false,"shares":19044,"price":2.86,"value":54465.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units."}],"balance_after":60956,"source":{"system":"sec-edgar","filing":"0001179110-20-006240","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911020006240/edgar.xml","form_type":"4"}},{"id":3147107,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-15T21:28:27.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest in full on May 14, 2021, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001179110-20-006113","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911020006113/edgar.xml","form_type":"4"}},{"id":3148840,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T10:02:29.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":250000,"price":34.4984,"value":8624600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 12, 2020. The actual sale prices ranged from a low of $33.034 to a high of $35.665, inclusive. Each Reporting Person undertakes to provide upon request of the SEC Staff, Castle Biosciences, Inc. or a Castle Biosciences, Inc. security holder full information regarding the number of shares sold at each price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1433577,"source":{"system":"sec-edgar","filing":"0001104659-20-061078","document":"tm209687d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920061078/tm209687d1_form4.xml","form_type":"4"}},{"id":3189065,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-04-01T21:33:06.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.64,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001382963-20-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296320000069/edgar.xml","form_type":"4"}},{"id":3199260,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-03-20T21:22:32.000Z","date":"2020-03-18","kind":"purchase","acquired":true,"shares":900000,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These securities were purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant  exercisable for one share of Common Stock, at an exercise price of $3.50 per share)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Warrants have a five-year term and are exercisable beginning 181 days after their issue date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Warrants have a five-year term and are exercisable beginning 181 days after their issue date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II  disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":900000,"derivative":{"exercise_price":3.5,"underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001382963-20-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296320000040/edgar.xml","form_type":"4"}},{"id":3199259,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-03-20T21:22:32.000Z","date":"2020-03-18","kind":"purchase","acquired":true,"shares":120000,"price":25,"value":3000000.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converts into ten shares of Common Stock for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These securities were purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant  exercisable for one share of Common Stock, at an exercise price of $3.50 per share)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock is convertible into common stock at any time, upon approval of the stockholders, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock is convertible into common stock at any time, upon approval of the stockholders, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II  disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":120000,"derivative":{"underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001382963-20-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296320000040/edgar.xml","form_type":"4"}},{"id":3256338,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-21T22:22:10.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":25000,"price":32.03,"value":800750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1683577,"source":{"system":"sec-edgar","filing":"0001104659-20-023968","document":"tm209687-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920023968/tm209687-1_4.xml","form_type":"4"}},{"id":3266661,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T22:22:11.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":25000,"price":32.01,"value":800250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1708577,"source":{"system":"sec-edgar","filing":"0001104659-20-022494","document":"tm209325-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920022494/tm209325-1_4.xml","form_type":"4"}},{"id":3271856,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T20:20:28.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vested fully on February 12, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vested fully on February 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":986,"derivative":{"underlying":"Common Stock","underlying_shares":1227},"source":{"system":"sec-edgar","filing":"0001127602-20-005592","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760220005592/form4.xml","form_type":"4"}},{"id":3271855,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-14T20:20:28.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":8452,"source":{"system":"sec-edgar","filing":"0001127602-20-005592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760220005592/form4.xml","form_type":"4"}},{"id":3281937,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T22:58:27.000Z","date":"2020-02-06","kind":"sale","acquired":false,"shares":25000,"price":31.03,"value":775750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1733577,"source":{"system":"sec-edgar","filing":"0001104659-20-014010","document":"tm207324-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920014010/tm207324-1_4.xml","form_type":"4"}},{"id":3285325,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-02-07T20:38:29.000Z","date":"2020-02-04","kind":"grant","acquired":true,"shares":986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest fully on February 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest fully on February 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2213,"derivative":{"underlying":"Common Stock","underlying_shares":986},"source":{"system":"sec-edgar","filing":"0001127602-20-004311","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760220004311/form4.xml","form_type":"4"}},{"id":3291481,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T20:10:02.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":25000,"price":31.061,"value":776525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1758577,"source":{"system":"sec-edgar","filing":"0001104659-20-010543","document":"tm206618d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920010543/tm206618d1_4.xml","form_type":"4"}},{"id":3291480,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T20:10:02.000Z","date":"2020-01-31","kind":"sale","acquired":false,"shares":25000,"price":30.0155,"value":750387.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1783577,"source":{"system":"sec-edgar","filing":"0001104659-20-010543","document":"tm206618d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920010543/tm206618d1_4.xml","form_type":"4"}},{"id":3297732,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-30T23:52:35.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":25000,"price":30.0197,"value":750492.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1808577,"source":{"system":"sec-edgar","filing":"0001104659-20-008862","document":"tv537385_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000110465920008862/tv537385_4.xml","form_type":"4"}},{"id":3358686,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-11-26T21:30:52.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":3005,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-19-058121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119058121/doc4.xml","form_type":"4"}},{"id":3358685,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-26T21:30:52.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":8314,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."}],"balance_after":0,"derivative":{"exercise_price":12.73,"expiration_date":"2029-01-08","underlying":"Common Stock","underlying_shares":8314},"source":{"system":"sec-edgar","filing":"0001209191-19-058121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119058121/doc4.xml","form_type":"4"}},{"id":3358684,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-26T21:30:52.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":1437096,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of August 7, 2019, by and among Avedro, Inc. (the \"Issuer\"), Glaukos Corporation (\"Parent\") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), on November 21, 2019, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each share of common stock of the Issuer (\"Issuer Common Stock\") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock (\"Parent Common Stock\").  The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-058121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119058121/doc4.xml","form_type":"4"}},{"id":3377587,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2019-11-08T02:49:39.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":1333333,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":1333333,"derivative":{"exercise_price":6,"exercise_date":"2020-05-07","expiration_date":"2024-11-07","underlying":"Common Stock","underlying_shares":666666.5},"source":{"system":"sec-edgar","filing":"0001382963-19-000138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296319000138/edgar.xml","form_type":"4"}},{"id":3377586,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-11-08T02:49:39.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":17301,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received, in connection with the Merger, in exchange for an employee stock option to acquire 30,000 Venus Concept Ltd. ordinary shares for $4.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of the Transaction Date, 8,285 of these options to acquire Common Stock of the Issuer are fully vested and exercisable.  Of the remaining balance, 361 options vest  and become exercisable monthly from November 8, 2019 through November 8, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Held by HealthQuest Capital Management Company, LLC (\"HQCM\"). Mr. Kong is the Managing Partner and controlling member of HQCM, and may be deemed to have sole voting and dispositive power with respect to the options held of record by HQCM.  Mr. Kong disclaims beneficial interest over all of the securities owned by HQCM except to the extent of his pecuniary interest therein."}],"balance_after":17301,"derivative":{"exercise_price":7.05,"expiration_date":"2027-11-08","underlying":"Common Stock","underlying_shares":17301},"source":{"system":"sec-edgar","filing":"0001382963-19-000138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296319000138/edgar.xml","form_type":"4"}},{"id":3377585,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T02:49:39.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":1333333,"price":3.75,"value":4999998.75,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These securities were purchased from the Issuer at a purchase price of $3.75 per unit, consisting of one share of Common Stock and a warrant exercisable for 0.5 shares of Common Stock, with two warrants exercisable for one share of Common Stock at an exercise price of $6.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":3995621,"source":{"system":"sec-edgar","filing":"0001382963-19-000138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296319000138/edgar.xml","form_type":"4"}},{"id":3377584,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T02:49:39.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":1094814,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Merger, upon the conversion of the outstanding principal and any accrued and unpaid interest of three 8% Convertible Promissory Notes issued by Venus Concept Ltd., dated as of June 25, 2019,  August 14, 2019 and August 21, 2019, in the original principal amounts of $2,500,000, $985,714.24 and $4,014,285.76, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":2662288,"source":{"system":"sec-edgar","filing":"0001382963-19-000138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296319000138/edgar.xml","form_type":"4"}},{"id":3377583,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T02:49:39.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":1567474,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received, in connection with the merger of a wholly-owned subsidiary of Restoration Robotics, Inc. with and into Venus Concept Ltd. (the \"Merger\"), in exchange for 2,272,548 shares, 98,807 shares and 346,620 shares of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock of Venus Concept Ltd., respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by HealthQuest Partners II, L.P. (\"HealthQuest\").  HealthQuest Venture Management II, L.L.C. (\"HQVM II\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interests therein."}],"balance_after":1567474,"source":{"system":"sec-edgar","filing":"0001382963-19-000138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000138296319000138/edgar.xml","form_type":"4"}},{"id":3452038,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Series F Preferred Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"other","acquired":false,"shares":14107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Immediately prior to the closing of the IPO, the warrant became exercisable for 11,572 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Immediately exercisable."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.02,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":11572},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452037,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"reported_value":1027882,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"reported_value","element":"transactionTotalValue","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":12.8,"underlying":"Common Stock","underlying_shares":83453},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452036,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":1198016,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":982785},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452035,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-3 Preferred Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":388669,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":318842},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452034,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-2 Preferred Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":436910,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":358416},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452033,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":19524,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16015},"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452032,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"purchase","acquired":true,"shares":62500,"price":16,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents a purchase from the underwriters in the Issuer's IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1833577,"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452031,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"sale","acquired":false,"shares":9,"price":16,"value":144.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 29, 2019, HealthQuest exercised a warrant to purchase 11,572 shares of the Issuer's common stock for approximately $0.02 per share. HealthQuest paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 9 of the warrant shares to pay the exercise price and issuing to HealthQuest the remaining 11,563 shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1771077,"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452030,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"other","acquired":true,"shares":11572,"price":0.02,"value":231.44,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1771086,"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452029,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":83453,"price":12.8,"value":1068198.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The principal amount of the Convertible Promissory Note held by HealthQuest was $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share of $16.00 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1759514,"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3452028,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":149099,"kind":"organization","name":"Sofinnova HealthQuest Partners, L.P.","position":1,"cik":"0001579382","reported_name":"Sofinnova HealthQuest Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149100,"kind":"organization","name":"HealthQuest Venture Management, L.L.C.","position":2,"cik":"0001783696","reported_name":"HealthQuest Venture Management, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40892,"kind":"person","name":"Kong Garheng","position":3,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-01T01:43:14.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":1676061,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock issued upon conversion of the Preferred Stock were calculated by first aggregating all series of Preferred Stock held by HealthQuest, in accordance with the terms of the Company's then-effective Certificate of Incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are directly held by Sofinnova HealthQuest Partners, L.P. (\"HealthQuest\"). HealthQuest Venture Management, L.L.C. (\"HQVM\"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein."}],"balance_after":1676061,"source":{"system":"sec-edgar","filing":"0001144204-19-037023","document":"tv526440_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000114420419037023/tv526440_4.xml","form_type":"4"}},{"id":3482377,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T20:27:21.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal monthly installments over 12 months starting one month after the grant date (June 19, 2019), provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.92,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001267602-19-000095","document":"wf-form4_156106242633721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000126760219000095/wf-form4_156106242633721.xml","form_type":"4"}},{"id":3486060,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-18T23:49:15.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on June 1, 2020, subject to Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on June 1, 2020, subject to Reporting Person's continuous service through such date."}],"balance_after":3005,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-19-037844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119037844/doc4.xml","form_type":"4"}},{"id":3523803,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-16T20:13:32.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest in full on May 15, 2020, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001179110-19-006152","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000117911019006152/edgar.xml","form_type":"4"}},{"id":3649630,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":8314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (x) June 1, 2020 and (y) the first anniversary of the first annual meeting of the Issuer's stockholders following the Issuer's initial public offering, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":8314,"derivative":{"exercise_price":12.73,"expiration_date":"2029-01-08","underlying":"Common Stock","underlying_shares":8314},"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}},{"id":3649629,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series CC Convertible Preferred Stock","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":535369,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":535369},"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}},{"id":3649628,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series BB Convertible Preferred Stock","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":561673,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":561673},"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}},{"id":3649627,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series AA Convertible Preferred Stock","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":87663,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":87663},"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}},{"id":3649626,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"purchase","acquired":true,"shares":142857,"price":14,"value":1999998.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":1437096,"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}},{"id":3649625,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T00:12:45.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":535369,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by HealthQuest Partners II, L.P. (\"HealthQuest\"). HealthQuest Venture Management II, L.L.C. (\"HealthQuest Management\") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein."}],"balance_after":1294239,"source":{"system":"sec-edgar","filing":"0001209191-19-011333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000120919119011333/doc4.xml","form_type":"4"}}],"next_cursor":"2019-02-20T00:12:45.000000Z,3649625"}